Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Squamous Cell Carcinoma of the Head or Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04634825
What this trial is testing

Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck NeoplasmsHead and Neck Squamous Cell Carcinoma
MacroGenics 62
Testing effectiveness (Phase 2)Study completedNCT01057589
What this trial is testing

Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Neoplasms
Eli Lilly and Company 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128693
What this trial is testing

A Single-center, Multicohort, Phase II Clinical Study Evaluating the Combination Therapy of Sacituzumab Tirumotecan in Patients With Unresectable, Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 60
Testing effectiveness (Phase 2)Ended earlyNCT03522584
What this trial is testing

Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma
University of Washington 6
Testing effectiveness (Phase 2)Study completedNCT00019331
What this trial is testing

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

Who this might be right for
Colorectal CancerEndometrial CancerHead and Neck Cancer+6 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT05808920
What this trial is testing

The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Royal Marsden NHS Foundation Trust 400
Early research (Phase 1)Study completedNCT00030498
What this trial is testing

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+83 more
National Cancer Institute (NCI) 75
Early research (Phase 1)Not Yet RecruitingNCT07807345
What this trial is testing

Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic

Who this might be right for
Head & Neck Squamous Cell CarcinomaNon-Small Cell Lung CancerEsophageal Cancer+5 more
Sutro Biopharma, Inc. 285
Testing effectiveness (Phase 2)Study completedNCT03422536
What this trial is testing

Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Basaloid CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaRecurrent Oropharyngeal Squamous Cell Carcinoma+21 more
University of Arizona 78
Testing effectiveness (Phase 2)Ended earlyNCT01852292
What this trial is testing

Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Novartis Pharmaceuticals 157
Large-scale testing (Phase 3)UnknownNCT03855384
What this trial is testing

Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN）

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 334
Early research (Phase 1)WithdrawnNCT03652233
What this trial is testing

Afatinib and Nivolumab as Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent Squamous Cell Carcinoma of the Head or NeckMetastatic Squamous Cell Carcinoma of the Head or NeckSquamous Cell Carcinoma
Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Large-scale testing (Phase 3)Looking for participantsNCT06589804
What this trial is testing

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaMetastatic Hypopharyngeal Squamous Cell CarcinomaMetastatic Laryngeal Squamous Cell Carcinoma+18 more
National Cancer Institute (NCI) 158
Not applicableStudy completedNCT04490564
What this trial is testing

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaNon Small Cell Lung CancerMelanoma
Pharmassist Ltd 135
Testing effectiveness (Phase 2)Study completedNCT00003264
What this trial is testing

Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Fox Chase Cancer Center 22
Testing effectiveness (Phase 2)Ended earlyNCT02706691
What this trial is testing

BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancer

Who this might be right for
FGFR Gene AmplificationFGFR1 Gene AmplificationFGFR2 Gene Amplification+7 more
University of Chicago 1
Testing effectiveness (Phase 2)Study completedNCT03620123
What this trial is testing

Phase II Study on the Optimization of Immunotherapy in Squamous Carcinoma of the Head and Neck

Who this might be right for
Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCarcinoma, Squamous Cell of Head and Neck
AIO-Studien-gGmbH 54
Testing effectiveness (Phase 2)Study completedNCT05323656
What this trial is testing

Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Calliditas Therapeutics Suisse SA 55
Testing effectiveness (Phase 2)Study completedNCT00084682
What this trial is testing

Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Stage IV Squamous Cell Carcinoma of the HypopharynxStage IV Squamous Cell Carcinoma of the LarynxStage IV Squamous Cell Carcinoma of the Lip and Oral Cavity+1 more
National Cancer Institute (NCI) 14
Next Page